Loading candles…
AstraZeneca Pharma India Ltd operates in the pharmaceutical and biopharmaceutical industries in India. As a subsidiary of the AstraZeneca Group, the company is involved in the manufacture, distribution, and marketing of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines targeting key therapeutic areas, including Oncology, Cardiovascular, Renal & Metabolism (CVRM), Respiratory & Immunology, and Rare Diseases. The company serves the Indian market by leveraging its parent group's research and development pipeline. No information is available regarding its incorporation year, founders, key management, or stock exchange listings.
| Results - FY25 |
| To consider and approve the financial results for the period ended December 31, 2025 |
| 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 7 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 14 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 30 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.